GML (GML) fundamentals
GML is a listed company, part of the Healthcare sector, listed on the NSE as GML (ISIN INE09A801015). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What GML does
Galaxy Medicare Limited is an India-based company engaged in the manufacturing, trading and exporting of medical devices, plasters of paris (POP) bandages and other surgical dressings in India. The Company is engaged in the manufacturing and branding of its own products under its flagship brands POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, and FIXCAN, among others. With a portfolio of 27 registered trademarks in India under various brand names, it offers a diverse range of POP bandages, medical tapes and bandages, other surgical dressings and external preparation products for wound care and wound management, including sterile surgical wound dressing, medical disposables, adhesive bandages, absorbent gauze, among others. Its products are supplied all over India to central and state government health departments, corporate and private hospitals, among others.
Valuation and market data
| Last close | ₹16.90 |
|---|---|
| Market capitalisation | ₹20 crore |
| Enterprise value | ₹21 crore |
| P/E (TTM) | 1.62 |
| Price to book | 0.83 |
| Price to sales (TTM) | 0.15 |
| Book value per share | ₹20.35 |
| Dividend yield | 207.10% |
| Sector | Healthcare |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹41 crore | ₹5 crore | ₹3 crore | 0.00 |
| Mar 2025 | ₹40 crore | ₹5 crore | ₹3 crore | 2.84 |
| Mar 2024 | ₹37 crore | ₹5 crore | ₹4 crore | 3.13 |
| Mar 2023 | ₹32 crore | ₹2 crore | ₹2 crore | 5.17 |
| Mar 2022 | ₹31 crore | ₹0 crore | ₹-0 crore | -0.70 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 73.0% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 27.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.